Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFERNANDES, Juliana Folloni
dc.contributor.authorNICHELE, Samantha
dc.contributor.authorDAUDT, Liane E.
dc.contributor.authorTAVARES, Rita B.
dc.contributor.authorSEBER, Adriana
dc.contributor.authorKERBAUY, Fabio R.
dc.contributor.authorKOLISKI, Adriana
dc.contributor.authorLOTH, Gisele
dc.contributor.authorVIEIRA, Ana K.
dc.contributor.authorDARRIGO-JUNIOR, Luiz G.
dc.contributor.authorROCHA, Vanderson
dc.contributor.authorGOMES, Alessandra A.
dc.contributor.authorCOLTURATO, Vergilio
dc.contributor.authorMANTOVANI, Luiz F.
dc.contributor.authorRIBEIRO, Andreza F.
dc.contributor.authorRIBEIRO, Lisandro L.
dc.contributor.authorKUWAHARA, Cilmara
dc.contributor.authorRODRIGUES, Ana L. M.
dc.contributor.authorZECCHIN, Victor G.
dc.contributor.authorCOSTA-CARVALHO, Beatriz T.
dc.contributor.authorCARNEIRO-SAMPAIO, Magda
dc.contributor.authorCONDINO-NETO, Antonio
dc.contributor.authorFASTH, Anders
dc.contributor.authorGENNERY, Andrew
dc.contributor.authorPASQUINI, Ricardo
dc.contributor.authorHAMERSCHLAK, Nelson
dc.contributor.authorBONFIM, Carmem
dc.date.accessioned2019-01-17T13:35:19Z
dc.date.available2019-01-17T13:35:19Z
dc.date.issued2018
dc.description.abstractThe results of hematopoietic stem cell transplant (HSCT) for primary immunodeficiency diseases (PID) have been improving over time. Unfortunately, developing countries do not experience the same results. This first report of Brazilian experience of HSCT for PID describes the development and results in the field. We included data from transplants in 221 patients, performed at 11 centers which participated in the Brazilian collaborative group, from July 1990 to December 2015. The majority of transplants were concentrated in one center (n=123). The median age at HSCT was 22months, and the most common diseases were severe combined immunodeficiency (SCID) (n=67) and Wiskott-Aldrich syndrome (WAS) (n=67). Only 15 patients received unconditioned transplants. Cumulative incidence of GVHD grades II to IV was 23%, and GVHD grades III to IV was 10%. The 5-year overall survival was 71.6%. WAS patients had better survival compared to other diseases. Most deaths (n=53) occurred in the first year after transplantation mainly due to infection (55%) and GVHD (13%). Although transplant for PID patients in Brazil has evolved since its beginning, we still face some challenges like delayed diagnosis and referral, severe infections before transplant, a limited number of transplant centers with expertise, and resources for more advanced techniques. Measures like newborn screening for SCID may hasten the diagnosis and ameliorate patients' conditions at the moment of transplant.eng
dc.description.indexMEDLINEeng
dc.identifier.citationJOURNAL OF CLINICAL IMMUNOLOGY, v.38, n.8, p.917-926, 2018
dc.identifier.doi10.1007/s10875-018-0564-1
dc.identifier.eissn1573-2592
dc.identifier.issn0271-9142
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30014
dc.language.isoeng
dc.publisherSPRINGER/PLENUM PUBLISHERSeng
dc.relation.ispartofJournal of Clinical Immunology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright SPRINGER/PLENUM PUBLISHERSeng
dc.subjectPrimary immunodeficiencieseng
dc.subjectstem cell transplantationeng
dc.subjectsevere combined immunodeficiencyeng
dc.subjectWiskott-Aldrich syndromeeng
dc.subjectLatin Americaeng
dc.subject.otherchronic granulomatous-diseaseeng
dc.subject.otherbone-marrow-transplantationeng
dc.subject.otherwiskott-aldrich-syndromeeng
dc.subject.otherlatin-american societyeng
dc.subject.otherversus-host-diseaseeng
dc.subject.otherlong-term survivaleng
dc.subject.otherposttransplant cyclophosphamideeng
dc.subject.otherhaploidentical bmteng
dc.subject.otheraplastic-anemiaeng
dc.subject.otherinborn-errorseng
dc.subject.wosImmunologyeng
dc.titleTransplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countrieseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countrySuécia
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisose
hcfmusp.author.externalNICHELE, Samantha:Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil
hcfmusp.author.externalDAUDT, Liane E.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
hcfmusp.author.externalTAVARES, Rita B.:Inst Nacl Canc, Rio De Janeiro, Brazil
hcfmusp.author.externalSEBER, Adriana:Univ Fed Sao Paulo, Inst Oncol Pediat, Sao Paulo, Brazil
hcfmusp.author.externalKERBAUY, Fabio R.:Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
hcfmusp.author.externalKOLISKI, Adriana:Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil
hcfmusp.author.externalVIEIRA, Ana K.:Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
hcfmusp.author.externalDARRIGO-JUNIOR, Luiz G.:Univ Sao Paulo, Hosp Clin, Ribeirao Preto, Brazil
hcfmusp.author.externalROCHA, Vanderson:Hosp Sirio Libanes, Sao Paulo, Brazil; Univ Oxford, Churchill Hosp, NHS BT, Oxford, England
hcfmusp.author.externalGOMES, Alessandra A.:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalCOLTURATO, Vergilio:Hosp Amaral Carvalho, Jau, SP, Brazil
hcfmusp.author.externalRIBEIRO, Andreza F.:Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
hcfmusp.author.externalRIBEIRO, Lisandro L.:Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil; Hosp Nossa Senhora Gracas, Curitiba, Parana, Brazil
hcfmusp.author.externalKUWAHARA, Cilmara:Hosp Infantil Pequeno Principe, Curitiba, Parana, Brazil
hcfmusp.author.externalRODRIGUES, Ana L. M.:Hosp Infantil Pequeno Principe, Curitiba, Parana, Brazil
hcfmusp.author.externalZECCHIN, Victor G.:Univ Fed Sao Paulo, Inst Oncol Pediat, Sao Paulo, Brazil
hcfmusp.author.externalCOSTA-CARVALHO, Beatriz T.:BRAGID, Grp Brasileiro Imunodeficiencias, Sao Paulo, Brazil
hcfmusp.author.externalFASTH, Anders:Univ Gothenburg, Dept Pediat, Gothenburg, Sweden
hcfmusp.author.externalGENNERY, Andrew:Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England
hcfmusp.author.externalPASQUINI, Ricardo:Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil; Hosp Nossa Senhora Gracas, Curitiba, Parana, Brazil
hcfmusp.author.externalHAMERSCHLAK, Nelson:Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
hcfmusp.author.externalBONFIM, Carmem:Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil; Hosp Nossa Senhora Gracas, Curitiba, Parana, Brazil; Hosp Infantil Pequeno Principe, Curitiba, Parana, Brazil
hcfmusp.citation.scopus14
hcfmusp.contributor.author-fmusphcJULIANA FOLLONI FERNANDES
hcfmusp.contributor.author-fmusphcLUIZ FERNANDO ALVES LIMA MANTOVANI
hcfmusp.contributor.author-fmusphcMAGDA MARIA SALES CARNEIRO SAMPAIO
hcfmusp.contributor.author-fmusphcANTONIO CONDINO NETO
hcfmusp.description.beginpage917
hcfmusp.description.endpage926
hcfmusp.description.issue8
hcfmusp.description.volume38
hcfmusp.origemWOS
hcfmusp.origem.pubmed30470982
hcfmusp.origem.scopus2-s2.0-85057133423
hcfmusp.origem.wosWOS:000453283000010
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAntoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5eng
hcfmusp.relation.referenceBACH FH, 1968, LANCET, V2, P1364eng
hcfmusp.relation.referenceBaker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007eng
hcfmusp.relation.referenceBolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408eng
hcfmusp.relation.referenceBonfim C, 2017, BIOL BLOOD MARROW TR, V23, P310, DOI 10.1016/j.bbmt.2016.11.006eng
hcfmusp.relation.referenceBrodsky RA, 2008, BONE MARROW TRANSPL, V42, P523, DOI 10.1038/bmt.2008.203eng
hcfmusp.relation.referenceBuckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703eng
hcfmusp.relation.referenceCarneiro-Sampaio M, 2013, J CLIN IMMUNOL, V33, P716, DOI 10.1007/s10875-013-9865-6eng
hcfmusp.relation.referenceCondino-Neto A, 2015, ALLERGOL IMMUNOPATH, V43, P493, DOI 10.1016/j.aller.2014.05.007eng
hcfmusp.relation.referenceCondino-Neto A, 2014, CLIN EXP IMMUNOL, V178, P16, DOI 10.1111/cei.12495eng
hcfmusp.relation.referenceCosta-Carvalho B, 2017, EXPERT REV CLIN IMMU, V13, P483, DOI 10.1080/1744666X.2017.1255143eng
hcfmusp.relation.referencede la Morena MT, 2017, J ALLERGY CLIN IMMUN, V139, P1282, DOI 10.1016/j.jaci.2016.07.039eng
hcfmusp.relation.referencede Oliveira EB, 2015, PEDIATR BLOOD CANCER, V62, P2101, DOI 10.1002/pbc.25674eng
hcfmusp.relation.referenceDvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-yeng
hcfmusp.relation.referenceEapen M, 2012, BIOL BLOOD MARROW TR, V18, P1438, DOI 10.1016/j.bbmt.2012.03.003eng
hcfmusp.relation.referenceEspinosa-Rosales FJ, 2016, J CLIN IMMUNOL, V36, P415, DOI 10.1007/s10875-016-0277-2eng
hcfmusp.relation.referenceEsteves I, 2015, BONE MARROW TRANSPL, V50, P685, DOI 10.1038/bmt.2015.20eng
hcfmusp.relation.referenceFasth A, 2009, AM J HEMATOL, V84, P469, DOI 10.1002/ajh.21454eng
hcfmusp.relation.referenceFernandes JF, 2012, BLOOD, V119, P2949, DOI 10.1182/blood-2011-06-363572eng
hcfmusp.relation.referenceGale RP, 2016, BONE MARROW TRANSPL, V51, P898, DOI 10.1038/bmt.2016.35eng
hcfmusp.relation.referenceGaspar HB, 2013, BLOOD, V122, P3749, DOI 10.1182/blood-2013-02-380105eng
hcfmusp.relation.referenceGATTI RA, 1968, LANCET, V2, P1366eng
hcfmusp.relation.referenceGennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015eng
hcfmusp.relation.referenceGLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001eng
hcfmusp.relation.referenceGriffith LM, 2016, J ALLERGY CLIN IMMUN, V138, P375, DOI 10.1016/j.jaci.2016.01.051eng
hcfmusp.relation.referenceGriffith LM, 2014, J ALLERGY CLIN IMMUN, V133, P335, DOI 10.1016/j.jaci.2013.07.052eng
hcfmusp.relation.referenceGungor T, 2014, LANCET, V383, P436, DOI [10.1016/s0140-6736(13)62069-3, 10.1016/S0140-6736(13)62069-3]eng
hcfmusp.relation.referenceHassan A, 2012, BLOOD, V120, P3615, DOI 10.1182/blood-2011-12-396879eng
hcfmusp.relation.referenceJaimovich G, 2017, BONE MARROW TRANSPL, V52, P798, DOI 10.1038/bmt.2017.48eng
hcfmusp.relation.referenceKanegae Marilia Pyles P., 2017, Rev. paul. pediatr., V35, P25, DOI 10.1590/1984-0462/;2017;35;1;00013eng
hcfmusp.relation.referenceKlein OR, 2016, BIOL BLOOD MARROW TR, V22, P895, DOI 10.1016/j.bbmt.2016.02.001eng
hcfmusp.relation.referenceKwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024eng
hcfmusp.relation.referenceLeiva LE, 2007, J CLIN IMMUNOL, V27, P101, DOI 10.1007/s10875-006-9052-0eng
hcfmusp.relation.referenceLuznik L, 2001, BLOOD, V98, P3456, DOI 10.1182/blood.V98.12.3456eng
hcfmusp.relation.referenceLuznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005eng
hcfmusp.relation.referenceMarciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028eng
hcfmusp.relation.referenceMazzucchelli JTL, 2014, J INVEST ALLERG CLIN, V24, P184eng
hcfmusp.relation.referenceMoratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376eng
hcfmusp.relation.referenceMorillo-Gutierrez B, 2016, BLOOD, V128, P440, DOI 10.1182/blood-2016-03-704015eng
hcfmusp.relation.referenceOuederni M, 2016, J CLIN IMMUNOL, V36, P437, DOI 10.1007/s10875-016-0293-2eng
hcfmusp.relation.referenceOzsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679eng
hcfmusp.relation.referencePai SY, 2014, CURR OPIN ALLERGY CL, V14, P521, DOI 10.1097/ACI.0000000000000115eng
hcfmusp.relation.referencePai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177eng
hcfmusp.relation.referenceParta M, 2015, J CLIN IMMUNOL, V35, P675, DOI 10.1007/s10875-015-0204-yeng
hcfmusp.relation.referenceKanegae MPP, 2016, J PEDIAT-BRAZIL, V92, P374, DOI 10.1016/j.jped.2015.10.006eng
hcfmusp.relation.referencePicard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9eng
hcfmusp.relation.referenceSchuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432eng
hcfmusp.relation.referenceShah NN, 2017, BIOL BLOOD MARROW TR, V23, P980, DOI 10.1016/j.bbmt.2017.03.016eng
hcfmusp.relation.referenceShekhovtsova Z, 2017, HAEMATOLOGICA, V102, P1112, DOI 10.3324/haematol.2016.158808eng
hcfmusp.relation.referenceShin CR, 2012, BONE MARROW TRANSPL, V47, P1428, DOI 10.1038/bmt.2012.31eng
hcfmusp.relation.referenceSlack J, 2017, J ALLERGY CLIN IMMUN, VS0091-6749, P30567eng
hcfmusp.relation.referenceSTORB R, 1983, ANN INTERN MED, V98, P461, DOI 10.7326/0003-4819-98-4-461eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication08e2a0ec-f7b1-4d3b-a822-f48837c7f87f
relation.isAuthorOfPublication7b4a093e-714b-4b57-a6fc-8b4df2479583
relation.isAuthorOfPublication4099332b-1c08-486f-924c-44ecd4ac0d94
relation.isAuthorOfPublicationf0c8070e-72fb-4564-93ba-1452aa0e8446
relation.isAuthorOfPublication.latestForDiscovery08e2a0ec-f7b1-4d3b-a822-f48837c7f87f
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_FERNANDES_Transplantation_of_Hematopoietic_Stem_Cells_for_Primary_Immunodeficiencies_2018.PDF
Tamanho:
657.67 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)